22.07 USD
-0.7 (-3.07%)
21.9102 USD
-0.16 (-0.72%)
Taking everything into account, AEHR scores 4 out of 10 in our fundamental rating. AEHR was compared to 113 industry peers in the Semiconductors & Semiconductor Equipment industry. While AEHR has a great health rating, there are worries on its profitability. While showing a medium growth rate, AEHR is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
In the past year AEHR was profitable.
AEHR had a negative operating cash flow in the past year.
In multiple years AEHR reported negative net income over the last 5 years.
In multiple years AEHR reported negative operating cash flow during the last 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of -4.62%, AEHR is doing worse than 65.49% of the companies in the same industry.
AEHR's Return On Equity of -5.44% is on the low side compared to the rest of the industry. AEHR is outperformed by 62.83% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -4.62% | ||
| ROE | -5.44% | ||
| ROIC | N/A |
ROA(3y)12.71%
ROA(5y)8.78%
ROE(3y)15.26%
ROE(5y)9.32%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
AEHR has a Gross Margin of 36.21%. This is in the lower half of the industry: AEHR underperforms 61.95% of its industry peers.
AEHR's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for AEHR so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 36.21% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.48%
GM growth 5Y1.57%
2. Health
2.1 Basic Checks
AEHR does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, AEHR has more shares outstanding
Compared to 5 years ago, AEHR has more shares outstanding
AEHR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
AEHR has an Altman-Z score of 18.86. This indicates that AEHR is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of AEHR (18.86) is better than 91.15% of its industry peers.
There is no outstanding debt for AEHR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 18.86 |
ROIC/WACCN/A
WACC10.72%
2.3 Liquidity
AEHR has a Current Ratio of 7.06. This indicates that AEHR is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of AEHR (7.06) is better than 85.84% of its industry peers.
AEHR has a Quick Ratio of 3.54. This indicates that AEHR is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 3.54, AEHR is in the better half of the industry, outperforming 69.03% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 7.06 | ||
| Quick Ratio | 3.54 |
3. Growth
3.1 Past
The earnings per share for AEHR have decreased strongly by -91.89% in the last year.
The Earnings Per Share has been growing by 243890.10% on average over the past years. This is a very strong growth
The Revenue has decreased by -3.23% in the past year.
The Revenue has been growing by 21.48% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-91.89%
EPS 3Y-27.89%
EPS 5Y243890.1%
EPS Q2Q%-85.71%
Revenue 1Y (TTM)-3.23%
Revenue growth 3Y5.07%
Revenue growth 5Y21.48%
Sales Q2Q%-16.39%
3.2 Future
Based on estimates for the next years, AEHR will show a very strong growth in Earnings Per Share. The EPS will grow by 30.92% on average per year.
The Revenue is expected to grow by 18.56% on average over the next years. This is quite good.
EPS Next Y-42.2%
EPS Next 2Y27.75%
EPS Next 3Y30.92%
EPS Next 5YN/A
Revenue Next Year-2.72%
Revenue Next 2Y15.31%
Revenue Next 3Y18.56%
Revenue Next 5YN/A
3.3 Evolution
Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
AEHR is valuated quite expensively with a Price/Earnings ratio of 245.22.
61.95% of the companies in the same industry are cheaper than AEHR, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 26.59. AEHR is valued rather expensively when compared to this.
The Price/Forward Earnings ratio is 90.16, which means the current valuation is very expensive for AEHR.
AEHR's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. AEHR is more expensive than 63.72% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 24.03, AEHR is valued quite expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 245.22 | ||
| Fwd PE | 90.16 |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
AEHR's earnings are expected to grow with 30.92% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)0
EPS Next 2Y27.75%
EPS Next 3Y30.92%
5. Dividend
5.1 Amount
No dividends for AEHR!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
22.07
-0.7 (-3.07%)
Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)
Earnings (Next)
Inst Owners69.61%
Inst Owner Change17.79%
Ins Owners6.24%
Ins Owner Change12.08%
Market Cap662.32M
Revenue(TTM)56.82M
Net Income(TTM)-6.65M
Analysts47.5
Price Target24.48 (10.92%)
Short Float %18.07%
Short Ratio3.94
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-3.5%
Min Revenue beat(2)-6.81%
Max Revenue beat(2)-0.19%
Revenue beat(4)1
Avg Revenue beat(4)-4.55%
Min Revenue beat(4)-12.25%
Max Revenue beat(4)1.05%
Revenue beat(8)4
Avg Revenue beat(8)-1.13%
Revenue beat(12)7
Avg Revenue beat(12)1.18%
Revenue beat(16)9
Avg Revenue beat(16)2.47%
PT rev (1m)0%
PT rev (3m)45.45%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-249.97%
EPS NY rev (1m)0%
EPS NY rev (3m)6.25%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-16.26%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-4.04%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 245.22 | ||
| Fwd PE | 90.16 | ||
| P/S | 11.66 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 5.41 | ||
| P/tB | 6.54 | ||
| EV/EBITDA | N/A |
EPS(TTM)0.09
EY0.41%
EPS(NY)0.24
Fwd EY1.11%
FCF(TTM)-0.54
FCFYN/A
OCF(TTM)-0.34
OCFYN/A
SpS1.89
BVpS4.08
TBVpS3.37
PEG (NY)N/A
PEG (5Y)0
Graham Number2.87
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -4.62% | ||
| ROE | -5.44% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 36.21% | ||
| FCFM | N/A |
ROA(3y)12.71%
ROA(5y)8.78%
ROE(3y)15.26%
ROE(5y)9.32%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.48%
GM growth 5Y1.57%
F-Score2
Asset Turnover0.39
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 228.43% | ||
| Cap/Sales | 10.89% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 7.06 | ||
| Quick Ratio | 3.54 | ||
| Altman-Z | 18.86 |
F-Score2
WACC10.72%
ROIC/WACCN/A
Cap/Depr(3y)210.71%
Cap/Depr(5y)168.36%
Cap/Sales(3y)3.9%
Cap/Sales(5y)2.78%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-91.89%
EPS 3Y-27.89%
EPS 5Y243890.1%
EPS Q2Q%-85.71%
EPS Next Y-42.2%
EPS Next 2Y27.75%
EPS Next 3Y30.92%
EPS Next 5YN/A
Revenue 1Y (TTM)-3.23%
Revenue growth 3Y5.07%
Revenue growth 5Y21.48%
Sales Q2Q%-16.39%
Revenue Next Year-2.72%
Revenue Next 2Y15.31%
Revenue Next 3Y18.56%
Revenue Next 5YN/A
EBIT growth 1Y-244.05%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year180.94%
EBIT Next 3Y87.64%
EBIT Next 5YN/A
FCF growth 1Y-335.82%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-219.08%
OCF growth 3YN/A
OCF growth 5YN/A
AEHR TEST SYSTEMS / AEHR FAQ
Can you provide the ChartMill fundamental rating for AEHR TEST SYSTEMS?
ChartMill assigns a fundamental rating of 4 / 10 to AEHR.
What is the valuation status of AEHR TEST SYSTEMS (AEHR) stock?
ChartMill assigns a valuation rating of 1 / 10 to AEHR TEST SYSTEMS (AEHR). This can be considered as Overvalued.
How profitable is AEHR TEST SYSTEMS (AEHR) stock?
AEHR TEST SYSTEMS (AEHR) has a profitability rating of 1 / 10.
How financially healthy is AEHR TEST SYSTEMS?
The financial health rating of AEHR TEST SYSTEMS (AEHR) is 8 / 10.